Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2361-2016Class I

Alere INRatio PT/INR Test Strips Model Number: 0100071, 0100139

Alere San Diego, Inc. / initiated 2016-07-11 / Terminated

Alere San Diego, Inc. began a recall of Alere INRatio PT/INR Test Strips Model Number: 0100071, 0100139 Product Usage: The INRatio/INRatio2 Test Strips perform a modified version of the one-stage... on . FDA classified it as Class I and gives the reason as "Alere San Diego is initiating a voluntary recall for the Alere INRatio/INRatio2 PT/INR Monitoring Systems (Test Strips and Meters). This action is being initiated as a result of patients who had a therapeutic or...". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-2361-2016
Classification
Class I
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Alere San Diego, Inc.
Product
Alere INRatio PT/INR Test Strips Model Number: 0100071, 0100139 Product Usage: The INRatio/INRatio2 Test Strips perform a modified version of the one-stage Prothrombin Time test, using a recombinant human thromboplastin reagent. The clot formed in the Prothrombin Time reaction is detected by a change in the electrical impedance of the sample during the coagulation process. The system consists of a monitor and disposable test strips. The monitor measures impedance, heats the test strip to the proper reaction temperature, and provides a user interface. The blood sample is applied to the Test Strip and the clotting reaction occurs on the Test Strip.
Product code
GJS Test, Time, Prothrombin
Reason for recall
Alere San Diego is initiating a voluntary recall for the Alere INRatio/INRatio2 PT/INR Monitoring Systems (Test Strips and Meters). This action is being initiated as a result of patients who had a therapeutic or near-therapeutic INR with the Alere INRatio/INRatio2 PT/INR Monitoring System but a significantly higher INR (outside of therapeutic range) when performed by a central laboratory.
FDA root cause
Other
Action
Alere issued a press release on July 11, 2016. An Urgent Medical Device Letter dated July 26, 2016 was sent to affected customers on July 29, 2016. The letter identified the affected product, problem and actions to be taken. The letter instructed customers to consult with their healthcare provider as soon as possible to transition to an alternate method of PT/INR testing and to contact the firm regarding return or disposal of unused product and obtaining device replacement from a different manufacturer. For questions contact the Alere INRatid1 Recall Hotline at 1-866-723-2535.
Distribution
Worldwide Distribution - US Nationwide and foreign distribution to the countries of: Argentina, Australia, Azerbaijan, Bangladesh, Belarus, Belgium, Brazil, Brunei Daruss, Canada, Chile, China, Colombia, Egypt, France, Hong Kong, India, Indonesia, Israel, Italy, Japan, Kazakhstan, Malaysia, Maldives, Netherlands, Russia, Rwanda, Singapore, South Africa, South Korea, Spain, Taiwan, Thailand, Trinidad, Ukraine, Uruguay, and Vietnam.
Product codes and lots
All Lots All Serial Numbers

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2361-2016
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2354-2016Class ITerminatedVoluntary: Firm initiated
Z-2355-2016Class ITerminatedVoluntary: Firm initiated
Z-2356-2016Class ITerminatedVoluntary: Firm initiated
Z-2357-2016Class ITerminatedVoluntary: Firm initiated
Z-2358-2016Class ITerminatedVoluntary: Firm initiated
Z-2359-2016Class ITerminatedVoluntary: Firm initiated
Z-2360-2016Class ITerminatedVoluntary: Firm initiated
Z-2361-2016Class ITerminatedVoluntary: Firm initiated
Z-2362-2016Class ITerminatedVoluntary: Firm initiated